In-vivo imaging of tumor associated urokinase-type plasminogen activator activity

Journal of Biomedical Optics

Volumn 11, Issue 3, 2006, Pages

  Hsiao, Jong Kai ^a,b   Law, Benedict ^a   Weissleder, Ralph ^a   Tung, Ching Hsuan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Fluorescence; Optical imaging; Protease; Tumor; Urokinase type plasminogen activator

Indexed keywords

ENZYMES; FLUORESCENCE; MEDICAL IMAGING; PROBES;

OPTICAL IMAGING; PLASMINOGEN ACTIVATOR; PROTEASE; UROKINASE;

TUMORS;

ANIMALIA;

TUMOR MARKER; TUMOR PROTEIN; UROKINASE;

ADENOCARCINOMA; ARTICLE; ENZYME ACTIVATION; ENZYMOLOGY; FIBROSARCOMA; FLUORESCENCE MICROSCOPY; HUMAN; INFRARED SPECTROPHOTOMETRY; METHODOLOGY; PATHOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; CELL LINE, TUMOR; ENZYME ACTIVATION; FIBROSARCOMA; HUMANS; MICROSCOPY, FLUORESCENCE; NEOPLASM PROTEINS; SPECTROPHOTOMETRY, INFRARED; TUMOR MARKERS, BIOLOGICAL; URINARY PLASMINOGEN ACTIVATOR;

EID: 33748474842     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.2204029     Document Type: Article

References (28)

1. S. A. Rabbani and A. P. Mazar, "The role of the plasminogen activation system in angiogenesis and metastasis", Surg. Oncol. Clin. N. Am. 10(2), 393-415 (2001). (Pubitemid 32472537)
2. P. F. Choong and A. P. Nadesapillai, "Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis", Clin. Orthop. Relat. Res. 415, suppl. S46-58 (2003). (Pubitemid 37323319)
3. J. S. Rao, "Molecular mechanisms of glioma invasiveness: the role of proteases", Nat. Rev. Cancer 3(7), 489-501 (2003). (Pubitemid 37328837)
4. A. J. Barrett, N. D. Rawlings, and J. F. Woessner, Handbook of Proteolytic Enzymes, Academic Press, San Diego (1998).
5. P. A. Andreasen, L. Kjoller, L. Christensen, and M. J. Duffy, "The urokinase-type plasminogen activator system in cancer metastasis: a review", Int. J. Cancer 72(1), 1-22 (1997). (Pubitemid 27314632)
6. J. A. Pettersen, M. E. Hudon, and M. D. Hill, "Intra-arterial thrombolysis in acute ischemic stroke: a review of pharmacologic approaches", Expert Rev. Cardiovasc. Ther. 2(2), 285-299 (2004). (Pubitemid 38701984)
7. P. A. Andreasen, L. Sottrup-Jensen, L. Kjoller, A. Nykjaer, S. K. Moestrup, C. M. Petersen, and J. Gliemann, "Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes", FEBS Lett. 338(3), 239-245 (1994). (Pubitemid 24056729)
8. F. Janicke, A. Prechtl, C. Thomssen, N. Harbeck, C. Meisner, M. Untch, C. G. J. F. Sweep, H. K. Selbmann, H. Graeff, and M. Schmitt, "Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinasetype plasminogen activator and plasminogen activator inhibitor type 1", J. Natl. Cancer Inst. 93(12), 913-920 (2001). (Pubitemid 32624648)
9. M. P. Look, W. L. J. van Putten, M. J. Duffy, N. Harbeck, I. J. Christensen, C. Thomssen, R. Kates, F. Spyratos, M. Ferno, S. Eppenberger-Castori, C. G. J. F. Sweep, K. Ulm, J. P. Peyrat, P. M. Martin, H. Magdelenat, N. Brunner, C. Duggan, B. W. Lisboa, P. O. Bendahl, V. Quillien, A. Daver, G. Ricolleau, M. E. Meijer-van Gelder, P. Manders, W. E. Fiets, M. A. Blankenstein, P. Broet, S. Romain, G. Daxenbichler, G. Windbichler, T. Cufer, S. Borstnar, W. Kueng, L. V. A. M. Beex, J. G. M. Klijn, N. O'Higgins, U. Eppenberger, F. Janicke, M. Schmitt, and J. A. Foekens, "Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients", J. Natl. Cancer Inst. 94(2), 116-128 (2002). (Pubitemid 34121291)
10. S. Ertongur, S. Lang, B. Mack, K. Wosikowski, B. Muehlenweg, and O. Gires, "Inhibition of the invasion capacity of carcinoma cells by WX-UK1, a novel synthetic inhibitor of the urokinase-type plasminogen activator system", Int. J. Cancer 110(6), 815-824 (2004). (Pubitemid 38758506)
11. A. Schweinitz, T. Steinmetzer, I. J. Banke, M. J. Arlt, A. Sturzebecher, O. Schuster, A. Geissler, H. Giersiefen, E. Zeslawska, U. Jacob, A. Kruger, and J. Sturzebecher, "Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agents", J. Biol. Chem. 279(32), 33613-33622 (2004). (Pubitemid 39063010)
12. H. Kobayashi, M. Suzuki, Y. Hirashima, and T. Terao, "The protease inhibitor bikunin, a novel anti-metastatic agent", Biol. Chem. 384(5), 749-754 (2003). (Pubitemid 36747936)
13. V. Magdolen, A. Kruger, S. Sato, J. Nagel, S. Sperl, U. Reuning, P. Rettenberger, U. Magdolen, and M. Schmitt, "Inhibition of the tumor-associated urokinase-type plasminogen activation system: effects of high-level synthesis of soluble urokinase receptor in ovarian and breast cancer cells in vitro and in vivo", Recent Results Cancer Res. 162, 43-63 (2003).
14. M. Funovics, R. Weissleder, and C. H. Tung, "Protease sensors for bioimaging", Anal. Bioanal. Chem. 377(6), 956-963 (2003). (Pubitemid 40877826)
15. B. Law, A. Curino, T. H. Bugge, R. Weissleder, and C. H. Tung, "Design, synthesis, and characterization of urokinase plasminogenactivator- sensitive near-infrared reporter", Chem. Biol. 11(1), 99-106 (2004). (Pubitemid 38203994)
16. A. Ginestra, M. D. La Placa, F. Saladino, D. Cassara, H. Nagase, and M. L. Vittorelli, "The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness", Anticancer Res. 18(5A), 3433-3437 (1998). (Pubitemid 28546471)
17. B. Law, J. K. Hsiao, T. H. Bugge, R. Weissleder, and C. H. Tung, "Novel optical zymography for specific detection of urokinase plasminogen activator in biological samples", Anal. Biochem. 338(1), 151-158 (2005). (Pubitemid 40228908)
18. U. Mahmood, C. H. Tung, A. Bogdanov, Jr., and R. Weissleder, "Near-infrared optical imaging of protease activity for tumor detection", Radiology 213(3), 866-870 (1999).
19. L. S. Reiter, E. K. Kruithof, J. F. Cajot, and B. Sordat, "The role of the urokinase receptor in extracellular matrix degradation by HT29 human colon carcinoma cells", Int. J. Cancer 53(3), 444-450 (1993). (Pubitemid 23047893)
20. M. A. Hudson and L. M. McReynolds, "Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines", J. Natl. Cancer Inst. 89(10), 709-717 (1997). (Pubitemid 27229859)
21. A. P. Mazar, "The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer", Anti-Cancer Drugs 12(5), 387-400 (2001). (Pubitemid 32643084)
22. C. Bremer, S. Bredow, U. Mahmood, R. Weissleder, and C. H. Tung, "Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model", Radiology 221(2), 523-529 (2001). (Pubitemid 33043440)
23. R. Weissleder, C. H. Tung, U. Mahmood, and A. Bogdanov, Jr., "In vivo imaging of tumors with protease-activated near-infrared fluorescent probes", Nat. Biotechnol. 17(4), 375-378 (1999). (Pubitemid 29166041)
24. C. H. Tung, U. Mahmood, S. Bredow, and R. Weissleder, "In vivo imaging of proteolytic enzyme activity using a novel molecular reporter", Cancer Res. 60(17), 4953-4958 (2000).
25. C. H. Tung, "Fluorescent peptide probes for in vivo diagnostic imaging", Biopolymers 76(5), 391-403 (2004).
26. G. Huet, F. Zerimech, M. C. Dieu, B. Hemon, G. Grard, M. Balduyck, A. Janin, R. Lafyatis, and P. Degand, "The state of differentiation of HT-29 colon carcinoma cells alters the secretion of cathepsin D and of plasminogen activator", Int. J. Cancer 57(6), 875-882 (1994). (Pubitemid 24216825)
27. L. S. Gutierrez, A. Schulman, T. Brito-Robinson, F. Noria, V. A. Ploplis, and F. J. Castellino, "Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1", Cancer Res. 60(20), 5839-5847 (2000).
28. M. A. Funovics, R. Weissleder, and U. Mahmood, "Catheter-based in vivo imaging of enzyme activity and gene expression: Feasibility study in mice", Radiology 231(3), 659-666 (2004). (Pubitemid 38668080)